Polyphenolic compounds like EGCG are known for their ability to modulate signal transduction mechanisms, which could lead to a cascade of events impacting the regulation of proteins like CCDC75. Similarly, curcumin has a broad spectrum of biological activities that can modify signaling pathways and protein interactions, thereby influencing CCDC75's function. Sodium butyrate, as a histone deacetylase inhibitor, and 1,1-Dimethylbiguanide, Hydrochloride, an AMPK activator, pivotally regulate gene expression and metabolic pathways, respectively. These actions can induce widespread changes in the cell, potentially affecting proteins that regulate or are associated with CCDC75. Kinase inhibitors like lithium chloride, U0126, and LY294002 specifically target signaling molecules such as GSK-3, MEK1/2, and PI3K, respectively. These inhibitors affect key regulatory pathways, which might have downstream effects on CCDC75.
Furthermore, compounds such as rapamycin, an mTOR inhibitor, have profound effects on protein synthesis and cell growth, which could indirectly influence the activity of CCDC75. In the realm of cellular stress and inflammation, SP600125 and SB203580, which inhibit JNK and p38 MAPK respectively, could alter the cellular response to stress and inflammatory signals, potentially modifying the role of CCDC75. Additionally, QNZ acts on one of the key transcription factors involved in immune response and cell survival, which might also contribute to the regulation of CCDC75.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Can modulate signal transduction pathways, possibly affecting proteins associated with CCDC75. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
A stilbenoid that activates SIRT1, an NAD+-dependent deacetylase, potentially influencing the acetylation status of proteins related to CCDC75. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Influences numerous signaling pathways and could alter protein interactions involving CCDC75. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
A short-chain fatty acid that acts as a histone deacetylase inhibitor, potentially affecting gene expression and protein modification linked to CCDC75. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
A glycogen synthase kinase 3 (GSK-3) inhibitor, could impact Wnt signaling and thus proteins that may interact with CCDC75. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, can influence various cellular processes and protein synthesis, potentially affecting CCDC75. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $42.00 $62.00 $153.00 $255.00 $500.00 $30.00 | 37 | |
An activator of AMP-activated protein kinase (AMPK) that may influence cellular metabolism and downstream proteins related to CCDC75. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can modulate stress response pathways, possibly affecting proteins that regulate CCDC75. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that might alter inflammatory response pathways and proteins associated with CCDC75. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
An inhibitor of MEK1/2, could impact the MAPK/ERK pathway and thus proteins interacting with CCDC75. |